OVER 6.2 MILLION adults in the United States have heart failure.1
Heart failure is a complex, progressive disease that can be challenging to manage.2,3 It is associated with a markedly poor prognosis and significantly reduced quality of life, leading to increased risk of death.2,3
Help your advanced heart failure patients understand if HeartMate 3 LVAD therapy might be a treatment option before their heart failure worsens.
Clinicians play a critical role in identifying heart failure progression early enough to help prevent heart failure-related hospitalizations, improve quality of life and extend survival for patients.
Even with optimal medical management, medications can become less effective as heart failure progresses. It’s important to recognize when medications alone are not enough, and when advanced therapies need to be considered for late stage heart failure patients.3
Fortunately, continuous innovation is creating more options for Mechanical Circulatory Support (MCS) patients with advanced heart failure, offering more hope for a better quality of life.
MAT-2012368 v3.0
